Marquis Top Doctors

Gary S. Roubin, MD, PhD

Title: Interventional Cardiology and Vascular Consultant
Company: Excision Medical Inc.
Location: Jackson, Wyoming, United States

Gary S. Roubin, MD, PhD, Interventional Cardiology and Vascular Consultant at Excision Medical Inc., has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in cardiology.

An internationally renowned interventional cardiologist celebrated for his groundbreaking work in the development of coronary stenting, the first FDA-approved coronary stent and his pioneering work in carotid stenting, embolic protection devices and large bore vascular closure technology, Dr. Roubin currently excels as an independent medical consultant, the director of InspireMD Inc., the director of Excision Medical Inc. and the director of Mountain Air Medical LLC. The former chairman of interventional cardiology at The University of Alabama at Birmingham and the department chairman and chief of service for the Cardiac and Vascular program at The Lenox Hill Hospital, he has been instrumental in the success of Cornerstone Inc. and Mednova Inc., whose acquisition by Abbott Vascular resulted in the top-selling carotid embolic protection system (NAV6) and stent system (XACT) in the U.S., and he was acknowledged as an inventor on 10 international patents as well as 41 additional patent applications. Moreover, he has been previously active as the medical director for the Cardiovascular Associates of the Southeast, the director and physician-in-chief with the Continuum Cardiovascular Centers of New York, a clinical professor of medicine at the New York University School of Medicine, the president of the medical board of The Lenox Hill Hospital, the director of neurovascular interventions at the Utah Heart Clinic and a professor of medicine and radiology at the University of Alabama in Birmingham. Most recently, Dr. Roubin co-founded Essential Medical Inc., which has had found success in bringing a large bore vascular closure device to the global marketplace. 

To support his professional endeavors, Dr. Roubin obtained a Bachelor of Veterinary Science, with honors, from the University of Queensland in 1970, a Bachelor of Medicine, Bachelor of Surgery from the University of Queensland in 1975, a Doctor of Philosophy from the University of Sydney in 1985, and a Doctor of Medicine in 1995. Having been integral to the development of device technology, innovative techniques for the treatment of coronary and peripheral atherosclerosis, he has also been recognized as a fellow of the American College of Cardiology, the Royal Australian College of Physicians, the Council on Clinical Cardiology of the American Heart Association, the Society for Cardiac Angiography and Intervention, and the Society for Vascular Medicine and Biology, to name a few. A prolific author with more than 280 papers published in peer-reviewed medical journals and a book, “The First Balloon Expandable Coronary Stent: An Expedition that Changed Cardiovascular Medicine,” available on Amazon, he has been further honored by his peers as profiled among the Best Doctors and Best Cardiologists in America for 25 years. Attributing his success to his good fortune, Dr. Roubin hopes to bring cardiac and vascular devices to patient care that will make a positive impact in clinical outcomes for patients.

For more information, please visit:
Press Release 

Contact Dr. Roubin:

Share with:


More to explore

Veronica Vlad

Title: Senior Director of Hematology, Oncology, and Global Project Management Company:  Thermo Fisher Scientific, Inc. Location: Spring, Texas, United States Veronica

Samantha Slotnick

Title: Optometrist and Clinical Director Company: Mind-Body-World Optometry Location: Scarsdale, New York, United States Samantha Slotnick, optometrist and clinical director at